Precise understanding of cancer biology and molecular medicine is required for evaluation of genomic alterations in cancer. To promote cancer genomic medicine in increasing numbers of hospitals by multidisciplinary collaboration, researchers specialized in such fields of sciences are expected to have chances to participate in the expert panel. Furthermore, more efforts of biological research should be made in education programs for oncologists at graduate schools.